Pomander, based on price sensitivity exercises I've seen in Europe, and looking across the pricing of proprietary ED drugs, I'd concur with the €35 to €54 range, let's say €60 tops. As you say, the out of pocket cost of Priligy is the benchmark. From memory, Priligy was launched at €12 to €20 per dose, dropped to around €7 when Menarini relaunched it.
Unit cost is more important than per dose cost and since Fortacin will only be available as one… Read More
After 25 years in corporate and commercial and working for or with way too many pharma, biotech and medtech companies of all sizes, hardly surprising that my diligence is perhaps a bit deeper and broader than that of the average punter.
I built a pretty decent sized set of notes when I was a PLE holder and took exactly the approach that in use when looking at licensing or investment opportunities (which is more or less my current day job). For the record… Read More
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.